INTERNATIONAL PATENT: SAMSUNG LIFE PUBLIC WELFARE FOUNDATION, 사회복지법인 삼성생명공익재단 FILES APPLICATION FOR "PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HEMORRHAGIC BRAIN DISEASES, COMPRISING, AS ACTIVE INGREDIENT, BDNF GENE-INTRODUCED MESENCHYMAL STEM CELLS OR EXTRACELLULAR VESICLES DERIVED THEREFROM"

GENEVA, March 24 -- SAMSUNG LIFE PUBLIC WELFARE FOUNDATION (48 Itaewon-ro 55-gil,Yongsan-gu,Seoul 04348), 사회복지법인 삼성생명공익재단 (서울특별시용산구이태원로55길 48) filed a patent application (PCT/KR2025/095499) for "PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HEMORRHAGIC BRAIN DISEASES, COMPRISING, AS ACTIVE INGREDIENT, BDNF GENE-INTRODUCED MESENCHYMAL STEM CELLS OR EXTRACELLULAR VESICLES DERIVED THEREFROM" on Aug 20, 2025. With publication no. WO/2026/059403, the details related to the patent application was published on Mar 19, 2026.

Notably, the patent applicati...